BRAF-Mutant Melanoma | Evolving Paradigms

Weber Compares BRAF/MEK, Immunotherapy Combos in Melanoma

July 16, 2016

Clinical Articles

With 2 different BRAF/MEK combination regimens approved by the FDA, as well as an immunotherapy combination, treatment and sequencing decisions for metastatic BRAF-mutated melanoma can be difficult.

Treatment Sequencing Considerations for BRAF-Mutant Melanoma

May 26, 2016

Clinical Articles

With expanding availability of effective single-agent and combination immunotherapies and combination BRAF/MEK inhibitor regimens, all of which have been shown to improve survival and reduce risk of progression, the optimal sequencing of therapies has become increasingly complex.

Combination Regimens for Metastatic Melanoma

May 25, 2016

Clinical Articles

A number of new combination approaches have gained approval in the past year for the treatment of patients with BRAF-mutant metastatic melanoma, expanding the number of effective treatment options that can improve quality and length of life for many patients.